_version_ 1784586151555760128
author Figueiredo, J.C.
Ihenacho, U.
Merin, N.M.
Hamid, O.
Darrah, J.
Gong, J.
Paquette, R.
Mita, A.C.
Vescio, R.
Mehmi, I.
Basho, R.
Salvy, S.J.
Shirazipour, C.H.
Caceres, N.
Finster, L.J.
Coleman, B.
Arnow, H.U.
Florindez, L.
Sobhani, K.
Prostko, J.C.
Frias, E.C.
Stewart, J.L.
Merchant, A.
Reckamp, K.L.
author_facet Figueiredo, J.C.
Ihenacho, U.
Merin, N.M.
Hamid, O.
Darrah, J.
Gong, J.
Paquette, R.
Mita, A.C.
Vescio, R.
Mehmi, I.
Basho, R.
Salvy, S.J.
Shirazipour, C.H.
Caceres, N.
Finster, L.J.
Coleman, B.
Arnow, H.U.
Florindez, L.
Sobhani, K.
Prostko, J.C.
Frias, E.C.
Stewart, J.L.
Merchant, A.
Reckamp, K.L.
author_sort Figueiredo, J.C.
collection PubMed
description
format Online
Article
Text
id pubmed-8527840
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Ltd on behalf of European Society for Medical Oncology.
record_format MEDLINE/PubMed
spelling pubmed-85278402021-10-21 SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment Figueiredo, J.C. Ihenacho, U. Merin, N.M. Hamid, O. Darrah, J. Gong, J. Paquette, R. Mita, A.C. Vescio, R. Mehmi, I. Basho, R. Salvy, S.J. Shirazipour, C.H. Caceres, N. Finster, L.J. Coleman, B. Arnow, H.U. Florindez, L. Sobhani, K. Prostko, J.C. Frias, E.C. Stewart, J.L. Merchant, A. Reckamp, K.L. Ann Oncol Letter to the Editor Published by Elsevier Ltd on behalf of European Society for Medical Oncology. 2022-01 2021-10-20 /pmc/articles/PMC8527840/ /pubmed/34687893 http://dx.doi.org/10.1016/j.annonc.2021.10.004 Text en © 2021 Published by Elsevier Ltd on behalf of European Society for Medical Oncology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Figueiredo, J.C.
Ihenacho, U.
Merin, N.M.
Hamid, O.
Darrah, J.
Gong, J.
Paquette, R.
Mita, A.C.
Vescio, R.
Mehmi, I.
Basho, R.
Salvy, S.J.
Shirazipour, C.H.
Caceres, N.
Finster, L.J.
Coleman, B.
Arnow, H.U.
Florindez, L.
Sobhani, K.
Prostko, J.C.
Frias, E.C.
Stewart, J.L.
Merchant, A.
Reckamp, K.L.
SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
title SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
title_full SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
title_fullStr SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
title_full_unstemmed SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
title_short SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
title_sort sars-cov-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527840/
https://www.ncbi.nlm.nih.gov/pubmed/34687893
http://dx.doi.org/10.1016/j.annonc.2021.10.004
work_keys_str_mv AT figueiredojc sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT ihenachou sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT merinnm sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT hamido sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT darrahj sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT gongj sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT paquetter sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT mitaac sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT vescior sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT mehmii sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT bashor sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT salvysj sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT shirazipourch sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT caceresn sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT finsterlj sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT colemanb sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT arnowhu sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT florindezl sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT sobhanik sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT prostkojc sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT friasec sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT stewartjl sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT merchanta sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment
AT reckampkl sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment